Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation

Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt

  • Matilde B. Ørum
  • Frederikke F. Rönsholt
  • Majbritt Jeppesen
  • Elisabeth Bendstrup
  • Terese L. Katzenstein
  • Peter Ott
  • Perch, Michael
  • Tacjana Pressler
  • Tavs Qvist
  • Søren Jensen-Fangel

We report a case series of four patients with cystic fibrosis (CF) and previous solid organ transplantation (SOT) receiving elexacaftor/tezacaftor/ivacaftor therapy for 6 months or more. Data was collected retrospectively. The treatment was well tolerated and all patients reported subjective improvements.

OriginalsprogEngelsk
TidsskriftPediatric Pulmonology
Vol/bind58
Udgave nummer2
Sider (fra-til)602-605
Antal sider4
ISSN8755-6863
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
The authors would like to thanks the patients and the staff involving in the care of patients with cystic fibrosis and solid organ transplantation in Denmark.

Publisher Copyright:
© 2022 Wiley Periodicals LLC.

ID: 340536792